運達科技(300440.SZ):上半年歸母淨利預降50%-30%
格隆匯7月9日丨運達科技(300440.SZ)公佈2021年半年度業績預吿,公司預計上半年歸屬於上市公司股東的淨利潤1958.40萬元–2741.75萬元,比上年同期下降50%-30%。
報吿期內公司業務進展順利,2021年上半年度營業收入較上年同期略有增長。公司上半年加大市場拓展力度,銷售費用同比有所上升。預計報吿期內非經常性損益對淨利潤的影響約260萬元。
公司因2021年4月購買的子公司成都貨安為同一控制下企業合併,最終控制方最早控制成都貨安的時間為2016年4月,本次預吿對上年同期進行追溯調整,上年同期數包含成都貨安2020年1-6月業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.